BioCentury | May 3, 2019
Emerging Company Profile

Vineti: Keeping cell therapies on track

...Ltd. Vineti raised a $33.5 million series B a year ago led by Canaan and DFJ...
...partners: GE Ventures, Mayo Clinic Number of employees: 85 Funds raised: $47.3 million Investors: Canaan, DFJ...
BioCentury | Dec 14, 2018
Financial News

Zymergen raises more than $400M in series C

...Goldman Sachs and Hanwha Asset Management joining existing investors DCVC, True Ventures, Two Sigma Ventures, DFJ...
BioCentury | Jul 20, 2018
Financial News

DFJ leads Verge Genmics' $32M series A round

...Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ...
...raised more than $36 million to date. Verge Genomics Inc., San Francisco, Calif. Business: Neurology Paul Bonanos DFJ Verge...
BioCentury | Jul 16, 2018
Financial News

DFJ leads Verge Genomics' $32M series A round

...Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ...
BioCentury | Jul 16, 2018
Finance

AI on the Verge

...intelligence-guided neurology company Verge Genomics Inc. sought an investor syndicate that reflected its multidisciplinary mind-set. DFJ...
...Zhang, Verge “The syndicate is roughly half-and-half life sciences and tech,” Zhang told BioCentury. While DFJ...
...such as Tesla Inc. (NASDAQ:TSLA) and SpaceX, formally Space Exploration Technologies Corp., she pointed to DFJ...
BioCentury | Mar 9, 2018
Financial News

AI drug discovery company Atomwise raises $51M series A

...Group and seed investor DCVC. Also participating were existing investors Y Combinator, Khosla Ventures and DFJ...
BioCentury | Mar 7, 2018
Financial News

AI drug discovery company Atomwise raises $51M series A

...Group and seed investor DCVC. Also participating were existing investors Y Combinator, Khosla Ventures and DFJ...
BioCentury | Apr 5, 2016
Financial News

Human Longevity raises $220M series B

...Human Longevity in 2014 with series A support from Illumina, Genting Group CEO KT Lim, DFJ...
BioCentury | Sep 1, 2014
Financial News

Median Technologies proposes private placement of units

...6 million Placement agent: Cowen Investors: New Enterprise Associates; Omega Funds; Abingworth Management; Auriga Partners; DFJ...
BioCentury | Aug 26, 2014
Financial News

Median Technologies raising EUR 20 million

...offering. Omega Fund Management and Abingworth also will participate, along with existing investors Auriga Partners; DFJ...
Items per page:
1 - 10 of 36
BioCentury | May 3, 2019
Emerging Company Profile

Vineti: Keeping cell therapies on track

...Ltd. Vineti raised a $33.5 million series B a year ago led by Canaan and DFJ...
...partners: GE Ventures, Mayo Clinic Number of employees: 85 Funds raised: $47.3 million Investors: Canaan, DFJ...
BioCentury | Dec 14, 2018
Financial News

Zymergen raises more than $400M in series C

...Goldman Sachs and Hanwha Asset Management joining existing investors DCVC, True Ventures, Two Sigma Ventures, DFJ...
BioCentury | Jul 20, 2018
Financial News

DFJ leads Verge Genmics' $32M series A round

...Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ...
...raised more than $36 million to date. Verge Genomics Inc., San Francisco, Calif. Business: Neurology Paul Bonanos DFJ Verge...
BioCentury | Jul 16, 2018
Financial News

DFJ leads Verge Genomics' $32M series A round

...Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round led by DFJ...
BioCentury | Jul 16, 2018
Finance

AI on the Verge

...intelligence-guided neurology company Verge Genomics Inc. sought an investor syndicate that reflected its multidisciplinary mind-set. DFJ...
...Zhang, Verge “The syndicate is roughly half-and-half life sciences and tech,” Zhang told BioCentury. While DFJ...
...such as Tesla Inc. (NASDAQ:TSLA) and SpaceX, formally Space Exploration Technologies Corp., she pointed to DFJ...
BioCentury | Mar 9, 2018
Financial News

AI drug discovery company Atomwise raises $51M series A

...Group and seed investor DCVC. Also participating were existing investors Y Combinator, Khosla Ventures and DFJ...
BioCentury | Mar 7, 2018
Financial News

AI drug discovery company Atomwise raises $51M series A

...Group and seed investor DCVC. Also participating were existing investors Y Combinator, Khosla Ventures and DFJ...
BioCentury | Apr 5, 2016
Financial News

Human Longevity raises $220M series B

...Human Longevity in 2014 with series A support from Illumina, Genting Group CEO KT Lim, DFJ...
BioCentury | Sep 1, 2014
Financial News

Median Technologies proposes private placement of units

...6 million Placement agent: Cowen Investors: New Enterprise Associates; Omega Funds; Abingworth Management; Auriga Partners; DFJ...
BioCentury | Aug 26, 2014
Financial News

Median Technologies raising EUR 20 million

...offering. Omega Fund Management and Abingworth also will participate, along with existing investors Auriga Partners; DFJ...
Items per page:
1 - 10 of 36